Request for Information: Literature Search and Summarization Tools
ID: 9112024Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFFOOD AND DRUG ADMINISTRATIONFDA OFFICE OF ACQ GRANT SVCSBeltsville, MD, 20705, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH (AJ11)

Original Source

https://sam.gov/opp/1d7565bfa518478e83cf94bad894844f/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking information on literature search and summarization tools to enhance drug safety research. The FDA aims to identify commercial tools that utilize artificial intelligence, particularly natural language processing (NLP), to assist in the classification, summarization, and extraction of relevant medical literature, addressing challenges in evaluating adverse drug reactions. This Request for Information (RFI) is part of a market research initiative and does not constitute a solicitation for contracts; interested parties are encouraged to submit their responses by the specified deadline to Ian Weiss at ian.weiss@fda.hhs.gov, with a focus on the tool's capabilities, interoperability, and validation methods.

    Point(s) of Contact
    Ian Weiss
    (301) 796-5728
    Ian.Weiss@fda.hhs.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Request for Information: Literature Search and Summarization Tools
    Currently viewing
    Sources Sought
    Similar Opportunities
    DM: Prediction Model Software
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking advanced prediction model software to enhance product quality and efficiency within its Division of Product Quality and Research (DPQR). The software must be capable of mining large and complex datasets to identify critical quality parameters and optimize product performance at a molecular level, particularly in a high-performance computing (HPC) environment. This procurement is vital for addressing product quality issues in pharmaceutical manufacturing and ensuring compliance with FDA standards. Interested vendors should contact Allison Meads at allison.meads@fda.hhs.gov or Steven Gagnon at steven.gagnon@fda.hhs.gov for further details, as the contract will follow a firm fixed price model with specific deliverables and a performance period extending until installation and warranty completion.
    Software Component Package Risk & Vulnerability Periodic Database
    Active
    Health And Human Services, Department Of
    The U.S. Food and Drug Administration (FDA) is seeking to award a firm fixed price purchase order for a Software Component Package Risk and Vulnerability Periodic Database to Dark Sky Technology, Inc. This procurement aims to enhance the cybersecurity of medical devices by acquiring a subscription service that reports known software vulnerabilities, which is critical for the FDA's Center for Devices and Radiological Health (CDRH) to effectively assess and mitigate risks associated with medical device software. The initiative is part of the FDA's response to the Food and Drug Omnibus Reform Act of 2022, emphasizing the importance of safeguarding public health in an evolving technological landscape. Interested parties can contact Brian Wodzisz at Brian.Wodzisz@fda.hhs.gov for further information, with the contract performance period extending up to five years.
    Facility Management System (FMS) Administration and Data Management
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified vendors for the administration and data management of its Facility Management System (FMS), utilizing the ARCHIBUS software. The contractor will be responsible for providing ongoing FMS support, ensuring compliance with federal reporting requirements, maintaining data integrity, and offering user training and technical assistance. This initiative is crucial for managing the FDA's facilities efficiently in response to increasing service demands and regulatory requirements, with the contract anticipated to span from March 24, 2025, to March 23, 2030. Interested parties must submit their responses, including a Vendor Feedback Form, to Nicholas Bisher and Kimberly Pennix by September 23, 2024, at 2:00 PM EST, as this is a Sources Sought Notice and not a solicitation for proposals.
    Engineering and Application Support Services
    Active
    Health And Human Services, Department Of
    The Food and Drug Administration (FDA) is seeking qualified small businesses to provide Engineering and Application Support Services aimed at modernizing its IT infrastructure and application environments. The procurement focuses on DevSecCXOps, Innovation, Modernization, and Engineering Services, with an emphasis on IT project management, infrastructure modernization, and operational support. This initiative is critical for enhancing the FDA's technological capabilities to ensure public health safety and streamline service delivery. Interested contractors must submit their responses by September 30, 2024, detailing their corporate profiles and relevant experience, with a projected contract value of up to $80 million. For further inquiries, potential bidders can contact Roosevelt Walker at roosevelt.walker@fda.hhs.gov.
    Software Bill of Materials (SBOM) Validation Comparison Set
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration's Center for Devices and Radiological Health (CDRH), is seeking to award a firm fixed price purchase order to MedCrypt, Inc. for the development of a Software Bill of Materials (SBOM) Validation Comparison Dataset. The primary objective of this procurement is to enhance cybersecurity for medical devices by providing a continuously updated dataset of known vulnerabilities, which will aid in the analysis of risks and potential exploits associated with software components used in these devices. This initiative is crucial for ensuring the safety and efficacy of healthcare technologies, particularly in light of recent legislative mandates under the Food and Drug Omnibus Reform Act of 2022. Interested parties can contact Brian Wodzisz at Brian.Wodzisz@fda.hhs.gov for further information regarding this opportunity.
    FDA Library Digital Subscription Services and Support
    Active
    Health And Human Services, Department Of
    The Food and Drug Administration (FDA) is seeking qualified vendors to provide digital subscription services and support for its library resources, aimed at enhancing access to credible scientific information for its staff. The procurement involves establishing a Blanket Purchase Agreement that consolidates subscription management, covering renewals and purchases of journals, databases, and training materials, while ensuring these resources are accessible through a secure online tracking system. This initiative is crucial for maintaining an extensive and well-managed library that supports the FDA's public health mission, ensuring reliable access to critical information for its employees. Interested vendors should submit their capabilities statements by September 23, 2024, to Vivianna Diaz at Vivianna.Diaz@fda.hhs.gov, with a total funding allowance of $450,000 for unforeseen subscription changes over the contract period from January 1, 2025, to January 31, 2030.
    Health Technology Capability Statement Collection
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA), is issuing a Request for Information (RFI) to collect contractor capability statements related to Defense Health Information Technology (IT). This initiative aims to evaluate vendors' capabilities as the sector evolves with emerging technologies, particularly focusing on the integration of Artificial Intelligence (AI) to enhance procurement decisions for fiscal year 2025. The RFI emphasizes the importance of fostering innovation and industrial health within the Defense Health IT sector, encouraging contractors to submit existing materials that outline their experience, skills, and relevant certifications in PDF format. Interested parties must submit their capability statements by December 31, 2024, at 11:59 PM Eastern Time, and can contact Sharjeel Javaid at sharjeel.j.javaid.civ@health.mil for further information.
    A--Request for Proposals - Phase I Clinical Trials
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking proposals for Phase I clinical trials aimed at developing small molecule and biologics therapeutics, as outlined in RFP No. 75N95024R00086. The selected contractor will be responsible for comprehensive services including protocol development, trial management, and reporting to regulatory agencies, with a focus on safety, tolerability, and pharmacokinetics of the investigational therapeutics. This initiative is crucial for advancing therapeutic development in the field of neurology, ensuring compliance with FDA and ICH GCP standards throughout the trial process. Proposals are due by October 3, 2024, with a contract performance period from April 1, 2025, to March 31, 2035, and a maximum contract value of $233,227,446. Interested parties can contact Evan C. Feely at evan.feely@nih.gov or +1 301 827 5301 for further information.
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for the preparation and distribution of research drug products under a presolicitation notice. The contract will involve acquiring, importing, and exporting drugs and chemical compounds, as well as developing and analyzing various drug dosage forms, including marijuana and nicotine research cigarettes, to support drug abuse and addiction research. This contract is critical for maintaining a reliable supply of authentic controlled and uncontrolled drug compounds for the research community, with an anticipated award of one indefinite delivery, indefinite quantity (IDIQ) contract over a five-year period. Interested parties must possess a current DEA registration and comply with FDA’s current Good Manufacturing Practices, with proposals due approximately 45 days after the release of the RFP, expected on or about September 20, 2024. For further inquiries, contact Scott Duernberger at scott.duernberger@nih.gov or 301-594-0670.
    Request for Information: Computer Aided Facility Management (CAFM) Software System
    Active
    Health And Human Services, Department Of
    The National Institutes of Health, specifically the National Cancer Institute (NCI), is seeking information regarding Computer-Aided Facility Management (CAFM) and Integrated Workplace Management Systems (IWMS) to support its operational needs. The NCI currently utilizes Planon software and is interested in identifying qualified vendors, particularly small businesses, that can provide either authorized reselling of Planon products or alternative commercially-available systems. This initiative is crucial for maintaining efficient facility operations across NCI's extensive real estate portfolio, which includes approximately 125 buildings and 8,500 users. Interested parties should submit their responses by email to Contract Specialist Renee Jones-Chuang at renee.jones-chuang@nih.gov, referencing notice number 75N91024Q00115, as there is no solicitation available at this time and no contract is anticipated to be awarded in Fiscal Year 2024.